ICON plc is a global contract research organization that provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government organizations across the drug and device lifecycle. The company offers clinical development services spanning all phases of trials, laboratory and manufacturing support, patient access solutions, and proprietary technology platforms for site selection, patient recruitment, and data analytics, serving clients through project-based contracts, milestone-based payments, and fee-for-service arrangements. ICON earns revenue from a diversified client base across multiple therapeutic areas and geographic regions, competing as one of a select group of large, integrated CROs with global scale, complex trial capabilities, and specialized expertise.